NIH Statement on World AIDS Day 2020
Cross-posted from NIAID Newsroom
Today on World AIDS Day, we reflect both on the remarkable progress that has been made against HIV as well as the considerable challenges that remain. We now have highly effective HIV treatment and prevention methods, and work is underway to address the remaining challenges in delivering these tools to the people who need them most, as well as to develop new interventions. The National Institutes of Health continues to advance rigorous, innovative research to prevent new HIV transmissions and improve the health of people with HIV worldwide.
This year the coronavirus disease 2019 (COVID-19) pandemic is creating great concern and uncertainty for people everywhere, including those affected by HIV. Notably, lessons we learned from involving affected communities in HIV research planning and implementation are informing our response to this new pandemic. NIH also is leveraging its HIV research infrastructure and expertise to conduct critical clinical trials evaluating investigational vaccines and monoclonal antibodies for COVID-19 prevention, as well as a variety of potential COVID-19 therapeutics.
In the face of the challenges posed by COVID-19, our work to address HIV has not slowed, reflecting the U.S. Government theme for this year’s World AIDS Day—Ending the HIV Epidemic: Resilience and Impact